Australis Scientific Pty Ltd. announced that it has raised funds in a round of funding led by new investor, Rohto Pharmaceutical Co.,Ltd. on October 25, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,888 JPY | -3.57% | -5.16% | +1.58% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.58% | 4.37B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Australis Scientific Pty Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd.